Erschienen in:
13.01.2016 | Commentary
A premature proposal for new liver cancer seromarkers
verfasst von:
Liu-Cheng Wu, Wen-Feng Gong, Jian-Hong Zhong
Erschienen in:
Tumor Biology
|
Ausgabe 4/2016
Einloggen, um Zugang zu erhalten
Excerpt
Optimal treatment of liver cancer depends on correctly determining whether tumors are primary hepatocellular carcinoma (HCC) or secondary carcinoma that metastasized from an extrahepatic source. Nearly all cancers that originate outside the liver can metastasize to that organ, raising the risk of misdiagnosis and suboptimal treatment. Indeed, the incidence of HCC in China is similar to that of metastatic liver carcinoma. While pathology provides the best method for differentiating primary and secondary cancer, it is rarely used preoperatively to diagnose liver cancer. …